• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症患者新发心房颤动的结局:225841 例患者的系统评价和荟萃分析。

Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients.

机构信息

Department of Cardiology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Geriatrics, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Am J Emerg Med. 2021 Apr;42:23-30. doi: 10.1016/j.ajem.2020.12.062. Epub 2021 Jan 5.

DOI:10.1016/j.ajem.2020.12.062
PMID:33429188
Abstract

BACKGROUND

The outcomes of new-onset atrial fibrillation (AF) during sepsis are inconsistent and inconclusive. This meta-analysis aims to provide a comprehensive description of the impact of new-onset AF on the prognosis of sepsis.

METHODS

Three electronic databases (PubMed, Embase, and the Cochrane Library) were searched for relevant studies. Meta-analysis was performed using odds ratios (OR) and 95% confidence intervals (CI) as effect measures.

RESULTS

A total of 225,841 patients from 13 individual studies were incorporated to the meta-analysis. The summary results revealed that new-onset AF during sepsis was associated with increased odds of in-hospital mortality (pooled OR: 2.09; 95% CI: 1.53-2.86; p < 001), post-discharge mortality (pooled OR: 2.44; 95% CI: 1.81-3.29; p < .001), and stroke (pooled OR:1.88; 95% CI: 1.13-3.14; p < .05). Results also indicated that the incidence of new-onset AF varied from 1.9% for mild sepsis to 46.0% for septic shock. Furthermore, compared to those without AF, people with new-onset AF had longer ICU and hospital stays, as well as a higher recurrence of AF.

CONCLUSIONS

New-onset AF is frequently associated with adverse outcomes in patients with sepsis. This is a clinical issue that warrants more attention and should be managed appropriately to prevent poor prognosis.

摘要

背景

脓毒症患者新发心房颤动(AF)的结局不一致且尚无定论。本荟萃分析旨在全面描述新发 AF 对脓毒症患者预后的影响。

方法

检索 3 个电子数据库(PubMed、Embase 和 Cochrane Library),寻找相关研究。使用比值比(OR)和 95%置信区间(CI)作为效应量进行荟萃分析。

结果

共纳入来自 13 项研究的 225841 例患者进行荟萃分析。汇总结果表明,脓毒症患者新发 AF 与住院期间死亡率(合并 OR:2.09;95%CI:1.53-2.86;p<001)、出院后死亡率(合并 OR:2.44;95%CI:1.81-3.29;p<0.001)和卒中(合并 OR:1.88;95%CI:1.13-3.14;p<.05)的发生风险增加相关。此外,新发 AF 的发生率从轻度脓毒症的 1.9%到感染性休克的 46.0%不等。与无 AF 患者相比,新发 AF 患者 ICU 入住时间和住院时间更长,AF 复发率更高。

结论

脓毒症患者新发 AF 常与不良预后相关。这是一个需要引起更多关注的临床问题,应适当管理以预防不良预后。

相似文献

1
Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients.脓毒症患者新发心房颤动的结局:225841 例患者的系统评价和荟萃分析。
Am J Emerg Med. 2021 Apr;42:23-30. doi: 10.1016/j.ajem.2020.12.062. Epub 2021 Jan 5.
2
Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis.新型冠状病毒肺炎合并心房颤动患者的结局:一项系统评价和荟萃分析。
Am J Emerg Med. 2021 Dec;50:661-669. doi: 10.1016/j.ajem.2021.09.050. Epub 2021 Sep 24.
3
New-onset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic.严重脓毒症中的新发房颤与中风及死亡风险:一项严格评价的主题
Neurologist. 2012 Jul;18(4):239-43. doi: 10.1097/NRL.0b013e31825fa850.
4
Prevalence, Outcomes, and Risk Factors of New-Onset Atrial Fibrillation in Critically Ill Patients.危重症患者新发房颤的患病率、结局及危险因素
Int Heart J. 2020 May 30;61(3):476-485. doi: 10.1536/ihj.19-511. Epub 2020 Apr 29.
5
Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.严重脓毒症住院患者新发心房颤动与中风和死亡事件相关。
JAMA. 2011 Nov 23;306(20):2248-54. doi: 10.1001/jama.2011.1615. Epub 2011 Nov 13.
6
New-Onset Atrial Fibrillation in Sepsis: A Narrative Review.脓毒症相关性新发心房颤动:一篇叙述性综述。
Semin Thromb Hemost. 2021 Feb;47(1):18-25. doi: 10.1055/s-0040-1714400. Epub 2020 Sep 23.
7
New-onset atrial fibrillation is associated with increased mortality in critically ill patients: a systematic review and meta-analysis.新发房颤与危重症患者死亡率增加相关:一项系统评价和荟萃分析。
Acta Cardiol. 2019 Apr;74(2):162-169. doi: 10.1080/00015385.2018.1477035. Epub 2018 Jul 5.
8
Epidemiology of new-onset paroxysmal atrial fibrillation in the General Intensive Care Unit population and after discharge from ICU. A retrospective epidemiological study.综合重症监护病房人群中新发阵发性心房颤动的流行病学及重症监护病房出院后的情况。一项回顾性流行病学研究。
Anaesthesiol Intensive Ther. 2015;47(4):309-14. doi: 10.5603/AIT.a2015.0040. Epub 2015 Jul 26.
9
Severe sepsis and septic shock in patients with pre-existing non-cardiac pulmonary hypertension: contemporary management and outcomes.患有预先存在的非心源性肺动脉高压的患者中的严重脓毒症和脓毒性休克:当代管理和结局。
Crit Care Resusc. 2013 Jun;15(2):103-9.
10
Does Atrial Fibrillation Deteriorate the Prognosis in Patients With Septic or Cardiogenic Shock?心房颤动是否会恶化脓毒症或心源性休克患者的预后?
Am J Cardiol. 2023 Oct 15;205:141-149. doi: 10.1016/j.amjcard.2023.07.008. Epub 2023 Aug 18.

引用本文的文献

1
Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis.触发诱导型房颤危重症患者的抗凝与血栓栓塞风险——一项系统评价与荟萃分析
Neth Heart J. 2025 Aug 28. doi: 10.1007/s12471-025-01978-9.
2
Sepsis-induced Atrial Fibrillation: Can We Predict and Prevent This High-Risk Complication?脓毒症诱发的心房颤动:我们能否预测并预防这种高风险并发症?
Cureus. 2025 Jun 5;17(6):e85387. doi: 10.7759/cureus.85387. eCollection 2025 Jun.
3
Comparative clinical profiles and outcomes of prior vs. concurrently diagnosed atrial fibrillation in acute ischaemic stroke: the implication of diagnosis timing.
急性缺血性卒中患者既往诊断与同时诊断心房颤动的临床特征及结局比较:诊断时机的影响
Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf107.
4
Risk Factors and Prognosis of New-Onset Atrial Fibrillation in Sepsis: A Nationwide Electronic Health Record Study.脓毒症中新发心房颤动的危险因素及预后:一项全国性电子健康记录研究
JACC Adv. 2025 Mar 27;4(4):101681. doi: 10.1016/j.jacadv.2025.101681.
5
New-Onset, But Not Chronic Atrial Fibrillation, Is a Significant Factor Contributing to Mortality Among Patients with Severe COVID-19.新发而非慢性心房颤动是导致重症 COVID-19 患者死亡的重要因素。
Med Sci Monit. 2025 Mar 11;31:e946192. doi: 10.12659/MSM.946192.
6
A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.关于凝血功能障碍和免疫激活对脓毒症患者新发心房颤动影响的系统评价。
PLoS One. 2025 Jan 29;20(1):e0318365. doi: 10.1371/journal.pone.0318365. eCollection 2025.
7
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
8
Research priorities for the study of atrial fibrillation during acute and critical illness: recommendations from the Symposium on Atrial Fibrillation in Acute and Critical Care.急性和危重症期间心房颤动研究的优先事项:急性和危重症护理中心房颤动研讨会的建议
BMC Proc. 2024 Nov 5;18(Suppl 22):23. doi: 10.1186/s12919-024-00309-x.
9
Amlexanox reduces new-onset atrial fibrillation risk in sepsis by downregulating S100A12: a Mendelian randomization study.氨来呫诺通过下调S100A12降低脓毒症中新发房颤的风险:一项孟德尔随机化研究
Front Cardiovasc Med. 2024 Oct 9;11:1401314. doi: 10.3389/fcvm.2024.1401314. eCollection 2024.
10
Development of an Extended Cardiovascular SOFA Score Component Reflecting Cardiac Dysfunction with Improved Survival Prediction in Sepsis: An Exploratory Analysis in the Sepsis and Elevated Troponin (SET) Study.开发一个反映心脏功能障碍的扩展心血管序贯器官衰竭评估(SOFA)评分组件,以改善脓毒症患者生存预测:脓毒症与肌钙蛋白升高(SET)研究中的探索性分析
J Intensive Care Med. 2025 Mar;40(3):320-330. doi: 10.1177/08850666241282294. Epub 2024 Oct 1.